Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1660, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IP chemo for ovarian cancer - when does it pay off?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 564, 2008-01 ,pp. :
Access to resources
Recommend
What does istradefylline have to `off'er in PD?
Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. :
Financial incentives: to pay or not to pay?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 552, 2008-01 ,pp. :
ER/PgR levels predictive of chemo benefit in breast cancer?
Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. :
Molecular Targeted Therapy in Ovarian Cancer: What is on the Horizon?
Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. :